vs
艾伯维（ABBV）与Innovative Eyewear Inc（LUCY）财务数据对比。点击上方公司名可切换其他公司
艾伯维的季度营收约是Innovative Eyewear Inc的17313.8倍（$16.6B vs $959.8K）。艾伯维净利率更高（10.9% vs -194.8%，领先205.8%）。Innovative Eyewear Inc同比增速更快（39.0% vs 10.0%）。艾伯维自由现金流更多（$4.9B vs $-1.4M）。过去两年Innovative Eyewear Inc的营收复合增速更高（58.2% vs 16.2%）
艾伯维是一家总部位于美国伊利诺伊州北芝加哥的制药企业，专注于研发、生产覆盖多种疾病领域的治疗药物，致力于为全球各地患者提供安全有效的临床解决方案，在全球医药行业拥有较高的知名度与影响力。
General Eyewear是一家总部位于伦敦的眼镜企业与品牌，由弗雷泽·莱恩于1990年代末创立。品牌最初名为Arckiv，主打原创眼镜设计，尤其在复古眼镜品类拥有深厚的专业积淀，是眼镜行业颇具特色的专业品牌。
ABBV vs LUCY — 直观对比
营收规模更大
ABBV
是对方的17313.8倍
$959.8K
营收增速更快
LUCY
高出28.9%
10.0%
净利率更高
ABBV
高出205.8%
-194.8%
自由现金流更多
ABBV
多$4.9B
$-1.4M
两年增速更快
LUCY
近两年复合增速
16.2%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $16.6B | $959.8K |
| 净利润 | $1.8B | $-1.9M |
| 毛利率 | 72.6% | 12.0% |
| 营业利润率 | 27.3% | — |
| 净利率 | 10.9% | -194.8% |
| 营收同比 | 10.0% | 39.0% |
| 净利润同比 | 8354.5% | 12.0% |
| 每股收益（稀释后） | $1.02 | $-0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABBVLUCY
| Q4 25 | $16.6B | $959.8K | ||
| Q3 25 | $15.8B | $668.1K | ||
| Q2 25 | $15.4B | $579.2K | ||
| Q1 25 | $13.3B | $454.5K | ||
| Q4 24 | $15.1B | $690.7K | ||
| Q3 24 | $14.5B | $253.6K | ||
| Q2 24 | $14.5B | $308.7K | ||
| Q1 24 | $12.3B | $383.5K |
净利润ABBVLUCY
| Q4 25 | $1.8B | $-1.9M | ||
| Q3 25 | $186.0M | $-1.8M | ||
| Q2 25 | $938.0M | $-2.1M | ||
| Q1 25 | $1.3B | $-1.8M | ||
| Q4 24 | $-22.0M | $-2.1M | ||
| Q3 24 | $1.6B | $-1.7M | ||
| Q2 24 | $1.4B | $-1.9M | ||
| Q1 24 | $1.4B | $-2.0M |
毛利率ABBVLUCY
| Q4 25 | 72.6% | 12.0% | ||
| Q3 25 | 66.4% | 36.6% | ||
| Q2 25 | 71.8% | -2.2% | ||
| Q1 25 | 70.0% | 48.5% | ||
| Q4 24 | 70.9% | 13.6% | ||
| Q3 24 | 70.9% | 23.4% | ||
| Q2 24 | 70.9% | 17.9% | ||
| Q1 24 | 66.7% | 1.8% |
营业利润率ABBVLUCY
| Q4 25 | 27.3% | — | ||
| Q3 25 | 12.1% | — | ||
| Q2 25 | 31.7% | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | -9.9% | — | ||
| Q3 24 | 26.5% | — | ||
| Q2 24 | 27.6% | — | ||
| Q1 24 | 22.7% | — |
净利率ABBVLUCY
| Q4 25 | 10.9% | -194.8% | ||
| Q3 25 | 1.2% | -274.8% | ||
| Q2 25 | 6.1% | -363.6% | ||
| Q1 25 | 9.6% | -391.4% | ||
| Q4 24 | -0.1% | -307.8% | ||
| Q3 24 | 10.8% | -678.5% | ||
| Q2 24 | 9.5% | -631.2% | ||
| Q1 24 | 11.1% | -514.1% |
每股收益（稀释后）ABBVLUCY
| Q4 25 | $1.02 | $-0.14 | ||
| Q3 25 | $0.10 | $-0.38 | ||
| Q2 25 | $0.52 | $-0.66 | ||
| Q1 25 | $0.72 | $-0.72 | ||
| Q4 24 | $-0.03 | $0.26 | ||
| Q3 24 | $0.88 | $-0.99 | ||
| Q2 24 | $0.77 | $-1.87 | ||
| Q1 24 | $0.77 | $-2.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.3B | $6.5M |
| 总债务越低越好 | $58.9B | — |
| 股东权益账面价值 | $-3.3B | $9.1M |
| 总资产 | $134.0B | $10.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ABBVLUCY
| Q4 25 | $5.3B | $6.5M | ||
| Q3 25 | $5.7B | $6.7M | ||
| Q2 25 | $6.5B | $7.6M | ||
| Q1 25 | $5.2B | $5.3M | ||
| Q4 24 | $5.6B | $2.6M | ||
| Q3 24 | $7.3B | $4.5M | ||
| Q2 24 | $13.2B | $5.9M | ||
| Q1 24 | $18.1B | $2.6M |
总债务ABBVLUCY
| Q4 25 | $58.9B | — | ||
| Q3 25 | $63.0B | — | ||
| Q2 25 | $63.0B | — | ||
| Q1 25 | $64.5B | — | ||
| Q4 24 | $60.3B | — | ||
| Q3 24 | $58.5B | — | ||
| Q2 24 | $58.0B | — | ||
| Q1 24 | $63.8B | — |
股东权益ABBVLUCY
| Q4 25 | $-3.3B | $9.1M | ||
| Q3 25 | $-2.6B | $10.3M | ||
| Q2 25 | $-183.0M | $11.3M | ||
| Q1 25 | $1.4B | $7.5M | ||
| Q4 24 | $3.3B | $9.1M | ||
| Q3 24 | $6.0B | $10.9M | ||
| Q2 24 | $6.8B | $7.3M | ||
| Q1 24 | $8.0B | $3.9M |
总资产ABBVLUCY
| Q4 25 | $134.0B | $10.1M | ||
| Q3 25 | $133.9B | $11.2M | ||
| Q2 25 | $137.2B | $11.9M | ||
| Q1 25 | $136.2B | $7.9M | ||
| Q4 24 | $135.2B | $9.8M | ||
| Q3 24 | $143.4B | $11.6M | ||
| Q2 24 | $141.9B | $7.9M | ||
| Q1 24 | $148.9B | $4.8M |
负债/权益比ABBVLUCY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 45.44× | — | ||
| Q4 24 | 18.15× | — | ||
| Q3 24 | 9.70× | — | ||
| Q2 24 | 8.56× | — | ||
| Q1 24 | 7.97× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.2B | $-1.4M |
| 自由现金流经营现金流 - 资本支出 | $4.9B | $-1.4M |
| 自由现金流率自由现金流/营收 | 29.4% | -142.5% |
| 资本支出强度资本支出/营收 | 2.0% | 1.8% |
| 现金转化率经营现金流/净利润 | 2.87× | — |
| 过去12个月自由现金流最近4个季度 | $17.8B | — |
8季度趋势，按日历期对齐
经营现金流ABBVLUCY
| Q4 25 | $5.2B | $-1.4M | ||
| Q3 25 | $7.0B | $-1.5M | ||
| Q2 25 | $5.2B | $-2.1M | ||
| Q1 25 | $1.6B | $-2.3M | ||
| Q4 24 | $7.0B | $-1.9M | ||
| Q3 24 | $5.4B | $-1.4M | ||
| Q2 24 | $2.3B | $-1.9M | ||
| Q1 24 | $4.0B | $-1.5M |
自由现金流ABBVLUCY
| Q4 25 | $4.9B | $-1.4M | ||
| Q3 25 | $6.6B | $-1.5M | ||
| Q2 25 | $4.9B | — | ||
| Q1 25 | $1.4B | $-2.4M | ||
| Q4 24 | $6.8B | $-2.0M | ||
| Q3 24 | $5.2B | — | ||
| Q2 24 | $2.0B | $-1.9M | ||
| Q1 24 | $3.8B | $-1.5M |
自由现金流率ABBVLUCY
| Q4 25 | 29.4% | -142.5% | ||
| Q3 25 | 42.1% | -226.3% | ||
| Q2 25 | 31.7% | — | ||
| Q1 25 | 10.5% | -517.4% | ||
| Q4 24 | 44.7% | -285.2% | ||
| Q3 24 | 35.9% | — | ||
| Q2 24 | 14.0% | -626.1% | ||
| Q1 24 | 31.3% | -391.1% |
资本支出强度ABBVLUCY
| Q4 25 | 2.0% | 1.8% | ||
| Q3 25 | 2.4% | 2.2% | ||
| Q2 25 | 1.7% | 0.0% | ||
| Q1 25 | 1.8% | 8.9% | ||
| Q4 24 | 1.9% | 3.8% | ||
| Q3 24 | 1.7% | 0.0% | ||
| Q2 24 | 1.7% | 1.1% | ||
| Q1 24 | 1.6% | 8.4% |
现金转化率ABBVLUCY
| Q4 25 | 2.87× | — | ||
| Q3 25 | 37.76× | — | ||
| Q2 25 | 5.49× | — | ||
| Q1 25 | 1.27× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.49× | — | ||
| Q2 24 | 1.66× | — | ||
| Q1 24 | 2.95× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
